<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4496">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01244529</url>
  </required_header>
  <id_info>
    <org_study_id>CR-201011</org_study_id>
    <nct_id>NCT01244529</nct_id>
  </id_info>
  <brief_title>Comparison of Lens Fit and Lens Power of a New Contact Lens to Two Marketed Contact Lenses in a Population of Soft Contact Lens Wearers</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the comparability of lens fit and lens power of a
      new contact lens to the lens fit and lens power of two marketed lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)</study_design>
  <primary_outcome>
    <measure>Lens Centration Acceptance</measure>
    <time_frame>after 15 minutes of contact lens wear</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigator evaluated as acceptable (centered/slightly decentered) or unacceptable (substantially decentered). Number of eyes in each category will be reported by lens. This is an aggregate reporting of the lenses, combining the different base curves into a category by lens type. This is done per protocol, due to this primary outcome not being stratified by base curve.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Gaze Lens Movement</measure>
    <time_frame>after 15 minutes of contact lens wear</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigator evaluated as acceptable (minimal or moderate movement) or unacceptable (insufficient or excessive movement). Percent of eyes in each category will be evaluated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fit Acceptability</measure>
    <time_frame>after 15 minutes of contact lens wear</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigator evaluated lens fit using a six point scale: 5-optimal...3-borderline acceptable...2-unacceptable. Percent of eyes in each category will be evaluated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New Lens Power Fit Match to Control Lenses</measure>
    <time_frame>after 15 minutes of contact lens wear</time_frame>
    <safety_issue>No</safety_issue>
    <description>The lens power fit of test lenses will be compared to control lenses to determine if the power matches. Percent of eyes with exact power fit will be evaluated.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>galy A Plus/ galy A / seno A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pair 1: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 2: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 3: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>galy A Plus / seno A / galy A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pair 1: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 2: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).
Pair 3: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>galy A / galy A Plus / seno A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pair 1: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 2: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 3: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>galy A / seno A / galy A Plus</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pair 1: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 2: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).
Pair 3: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>seno A / galy A / glay A Plus</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pair 1: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).
Pair 2: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 3: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>seno A / galy A Plus / galy A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pair 1: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).
Pair 2: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).
Pair 3: galy A -subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>galy A Plus</intervention_name>
    <description>galyfilcon A Plus, BC: 8.3 or 8.7</description>
    <arm_group_label>galy A Plus/ galy A / seno A</arm_group_label>
    <arm_group_label>galy A Plus / seno A / galy A</arm_group_label>
    <arm_group_label>galy A / galy A Plus / seno A</arm_group_label>
    <arm_group_label>galy A / seno A / galy A Plus</arm_group_label>
    <arm_group_label>seno A / galy A / glay A Plus</arm_group_label>
    <arm_group_label>seno A / galy A Plus / galy A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>seno A</intervention_name>
    <description>senofilcon A, BC:8.4 or 8.8</description>
    <arm_group_label>galy A Plus/ galy A / seno A</arm_group_label>
    <arm_group_label>galy A Plus / seno A / galy A</arm_group_label>
    <arm_group_label>galy A / galy A Plus / seno A</arm_group_label>
    <arm_group_label>galy A / seno A / galy A Plus</arm_group_label>
    <arm_group_label>seno A / galy A / glay A Plus</arm_group_label>
    <arm_group_label>seno A / galy A Plus / galy A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>galy A</intervention_name>
    <description>galyfilcon A , BC: 8.3 or 8.7</description>
    <arm_group_label>galy A Plus/ galy A / seno A</arm_group_label>
    <arm_group_label>galy A Plus / seno A / galy A</arm_group_label>
    <arm_group_label>galy A / galy A Plus / seno A</arm_group_label>
    <arm_group_label>galy A / seno A / galy A Plus</arm_group_label>
    <arm_group_label>seno A / galy A / glay A Plus</arm_group_label>
    <arm_group_label>seno A / galy A Plus / galy A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be at least 18 years of age and no more than 55 years of age.

          -  Must sign written informed consent.

          -  Optimal spherical equivalent distance correction must be between -1.00 and -6.00
             diopters.

          -  Have spectacle astigmatism â‰¤ -0.75 diopter cylinder in both eyes.

          -  Must have visual acuity best correctable to 20/25+3 or better for each eye.

          -  Must appear able and willing to adhere to the instructions set forth in this clinical
             protocol.

          -  Have normal eyes with no evidence of abnormality or disease. For the purposes of this
             study a normal eye is defined as one having: No evidence of lid abnormality or
             infection; No conjunctival abnormality or infection; No clinical significant slit
             lamp findings, (i.e., oedema, staining, scarring, vascularization, infiltrates or
             abnormal opacities); No other active ocular disease.

          -  The subject is a current spherical soft contact lens wearer (defined as a minimum of
             6 hours of daily wear for a minimum of 1 month prior to the study) and willing to
             wear the study lenses on a daily wear basis (defined as a minimum of 6 hours of wear
             per day at least five days of the week) for the duration of the study.

        Exclusion Criteria:

          -  Any systemic illness which would contraindicate lens wear or the medical treatment of
             which would affect vision or successful lens wear.

          -  Any previous eye surgery involving the anterior segment.

          -  Pre-existing ocular disease that would preclude contact lens fitting.

          -  Abnormal lacrimal secretions.

          -  Keratoconus or other corneal irregularity.

          -  Pregnancy, lactating or planning a pregnancy at the time of enrollment.

          -  Participation in any concurrent clinical trial.

          -  Subject's habitual contact lens type is toric or multifocal.

          -  Require any concurrent ocular medication.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Farnham</city>
        <state>Surrey</state>
        <zip>GU9 7EN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <zip>B4 7ET</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <lastchanged_date>December 21, 2015</lastchanged_date>
  <firstreceived_date>November 17, 2010</firstreceived_date>
  <firstreceived_results_date>December 19, 2011</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>All Arms, All Interventions</title>
          <description>All subjects wore all intervention throughout the course of the study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All enrolled subjects.</population>
      <group_list>
        <group group_id="B1">
          <title>All Subjects</title>
          <description>All subjects who where enrolled wore all intervention lenses throughout the course of the study. The specific lenses used include the following: senofilcon A (control) soft contact lens with 8.8 base; senofilcon A (control) soft contact lens with 8.4 base curve; galyfilcon A (control) soft contact lens with 8.7 base curve; galyfilcon A (control) soft contact lens with 8.3 base curve; galyfilcon A Plus (test) soft contact lens with 8.7 base curve; galyfilcon A Plus (test) soft contact lens with 8.3 base curve.</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="41"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="34.0" spread="12.4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="21"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United Kingdom</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="41"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lens Centration Acceptance</title>
        <description>Investigator evaluated as acceptable (centered/slightly decentered) or unacceptable (substantially decentered). Number of eyes in each category will be reported by lens. This is an aggregate reporting of the lenses, combining the different base curves into a category by lens type. This is done per protocol, due to this primary outcome not being stratified by base curve.</description>
        <time_frame>after 15 minutes of contact lens wear</time_frame>
        <safety_issue>No</safety_issue>
        <population>Analysis was on those completed subjects who were enrolled, randomized, and assigned to a study arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Plus (Test)</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A (Control)</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O3">
            <title>Senofilcon A</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of eyes analyzed</title>
            <units>eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="82"/>
                  <measurement group_id="O2" value="82"/>
                  <measurement group_id="O3" value="82"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Lens Centration Acceptance</title>
            <description>Investigator evaluated as acceptable (centered/slightly decentered) or unacceptable (substantially decentered). Number of eyes in each category will be reported by lens. This is an aggregate reporting of the lenses, combining the different base curves into a category by lens type. This is done per protocol, due to this primary outcome not being stratified by base curve.</description>
            <units>eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Acceptable centration</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="74"/>
                  <measurement group_id="O2" value="62"/>
                  <measurement group_id="O3" value="69"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Unacceptable centration</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="20"/>
                  <measurement group_id="O3" value="13"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Gaze Lens Movement</title>
        <description>Investigator evaluated as acceptable (minimal or moderate movement) or unacceptable (insufficient or excessive movement). Percent of eyes in each category will be evaluated.</description>
        <time_frame>after 15 minutes of contact lens wear</time_frame>
        <safety_issue>No</safety_issue>
        <population>Analysis was on those completed subjects who were enrolled, randomized, and assigned to a study arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon AP 8.3 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A 8.3 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O3">
            <title>Senofilcon A 8.4 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O4">
            <title>Galyfilcon AP 8.7 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O5">
            <title>Galyfilcon A 8.7 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O6">
            <title>Senofilcon A 8.8 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="41"/>
                  <measurement group_id="O4" value="41"/>
                  <measurement group_id="O5" value="41"/>
                  <measurement group_id="O6" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of eyes analyzed</title>
            <units>eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="41"/>
                  <measurement group_id="O4" value="41"/>
                  <measurement group_id="O5" value="41"/>
                  <measurement group_id="O6" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Primary Gaze Lens Movement</title>
            <description>Investigator evaluated as acceptable (minimal or moderate movement) or unacceptable (insufficient or excessive movement). Percent of eyes in each category will be evaluated.</description>
            <units>percentage of eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Acceptable movement</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="93"/>
                  <measurement group_id="O2" value="93"/>
                  <measurement group_id="O3" value="100"/>
                  <measurement group_id="O4" value="93"/>
                  <measurement group_id="O5" value="90"/>
                  <measurement group_id="O6" value="98"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Unacceptable movement</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7"/>
                  <measurement group_id="O2" value="7"/>
                  <measurement group_id="O3" value="0"/>
                  <measurement group_id="O4" value="7"/>
                  <measurement group_id="O5" value="10"/>
                  <measurement group_id="O6" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fit Acceptability</title>
        <description>Investigator evaluated lens fit using a six point scale: 5-optimal...3-borderline acceptable...2-unacceptable. Percent of eyes in each category will be evaluated.</description>
        <time_frame>after 15 minutes of contact lens wear</time_frame>
        <safety_issue>No</safety_issue>
        <population>Analysis was on those completed subjects who were enrolled, randomized, and assigned to a study arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon AP 8.3 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A 8.3 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O3">
            <title>Senofilcon A 8.4 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O4">
            <title>Galyfilcon AP 8.7 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O5">
            <title>Galyfilcon A 8.7 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O6">
            <title>Senofilcon A 8.8 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="41"/>
                  <measurement group_id="O4" value="41"/>
                  <measurement group_id="O5" value="41"/>
                  <measurement group_id="O6" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of eyes analyzed</title>
            <units>eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="41"/>
                  <measurement group_id="O4" value="41"/>
                  <measurement group_id="O5" value="41"/>
                  <measurement group_id="O6" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Fit Acceptability</title>
            <description>Investigator evaluated lens fit using a six point scale: 5-optimal...3-borderline acceptable...2-unacceptable. Percent of eyes in each category will be evaluated.</description>
            <units>percentage of eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Acceptable Fit</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="90"/>
                  <measurement group_id="O2" value="90"/>
                  <measurement group_id="O3" value="95"/>
                  <measurement group_id="O4" value="83"/>
                  <measurement group_id="O5" value="71"/>
                  <measurement group_id="O6" value="80"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Unacceptable Fit</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="10"/>
                  <measurement group_id="O3" value="5"/>
                  <measurement group_id="O4" value="17"/>
                  <measurement group_id="O5" value="29"/>
                  <measurement group_id="O6" value="20"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>New Lens Power Fit Match to Control Lenses</title>
        <description>The lens power fit of test lenses will be compared to control lenses to determine if the power matches. Percent of eyes with exact power fit will be evaluated.</description>
        <time_frame>after 15 minutes of contact lens wear</time_frame>
        <safety_issue>No</safety_issue>
        <population>Analysis was on those completed subjects who were enrolled, randomized, and assigned to a study arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon AP 8.3 BC vs Galyfilcon A 8.3 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon AP 8.3 BC vs Senofilcon A 8.4 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O3">
            <title>Galyfilcon AP 8.7 BC vs Galyfilcon A 8.7 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
          <group group_id="O4">
            <title>Galyfilcon AP 8.7 BC vs Senofilcon A 8.8 BC</title>
            <description>All subjects wore each of the lenses at a point in the study as this was a contralateral study.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="41"/>
                  <measurement group_id="O4" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of eyes analyzed</title>
            <units>eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="41"/>
                  <measurement group_id="O4" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>New Lens Power Fit Match to Control Lenses</title>
            <description>The lens power fit of test lenses will be compared to control lenses to determine if the power matches. Percent of eyes with exact power fit will be evaluated.</description>
            <units>percentage of eyes</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Lens Power the Same</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="98"/>
                  <measurement group_id="O2" value="98"/>
                  <measurement group_id="O3" value="98"/>
                  <measurement group_id="O4" value="98"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Lens Power Not the Same</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="2"/>
                  <measurement group_id="O3" value="2"/>
                  <measurement group_id="O4" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>All Arms, All Interventions</title>
          <description>All subjects wore all intervention throughout the course of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication requires agreement and written authorization from Sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kathy Osborn, OD</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care</organization>
      <phone>1-904-443-1032</phone>
      <email>kosborn@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
